ZS Associates Archives -

Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an answer in the

Why real patient centricity is more essential than ever before

https://pharmaphorum.com/patients/why-real-patient-centricity-is-more-essential-than-ever-before/

New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap Bridging the

Patient centricity is becoming business critical for pharma

https://pharmaphorum.com/patients/patient-centricity-is-becoming-business-critical-for-pharma/

By Mary Iyiola & Agnieszka Janska, with additional consultation by Smita Sealey & Barry Farrimond In a recent

Innovative contracting in Europe: a Trojan Horse?

https://pharmaphorum.com/views-analysis-market-access/innovative-contracting-in-europe-a-trojan-horse-2/

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there

Cost & Management of Oncology Combination Regimens

https://pharmaphorum.com/oncology/cost-management-of-oncology-combination-regimens/

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing

Innovative contracting in Europe – a Trojan horse?

https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/

ZS Associates